{
  "paper_metadata": {
    "pmid": "15930086",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted information on the TTR gene variant Val30Met, including penetrance data and individual patient details."
  },
  "variants": [
    {
      "gene_symbol": "TTR",
      "cdna_notation": "c.148G>A",
      "protein_notation": "p.Val50Met",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 9,
        "demographics": "8 families, specific demographics not detailed",
        "phenotype": "fatal neuropathic amyloidosis (FAP)"
      },
      "penetrance_data": {
        "total_carriers_observed": 9,
        "affected_count": 9,
        "unaffected_count": 0,
        "uncertain_count": 0,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P1",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": null,
          "affected_status": "affected",
          "phenotype_details": "neuropathic amyloidosis",
          "evidence_sentence": "In Sweden, nine homozygous patients from eight families carrying the ATTR mutation Val30Met... have been identified."
        },
        {
          "individual_id": "P2",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": null,
          "affected_status": "affected",
          "phenotype_details": "neuropathic amyloidosis",
          "evidence_sentence": "In Sweden, nine homozygous patients from eight families carrying the ATTR mutation Val30Met... have been identified."
        },
        {
          "individual_id": "P3",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": null,
          "affected_status": "affected",
          "phenotype_details": "neuropathic amyloidosis",
          "evidence_sentence": "In Sweden, nine homozygous patients from eight families carrying the ATTR mutation Val30Met... have been identified."
        },
        {
          "individual_id": "P4",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": null,
          "affected_status": "affected",
          "phenotype_details": "neuropathic amyloidosis",
          "evidence_sentence": "In Sweden, nine homozygous patients from eight families carrying the ATTR mutation Val30Met... have been identified."
        },
        {
          "individual_id": "P5",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": null,
          "affected_status": "affected",
          "phenotype_details": "neuropathic amyloidosis",
          "evidence_sentence": "In Sweden, nine homozygous patients from eight families carrying the ATTR mutation Val30Met... have been identified."
        },
        {
          "individual_id": "P6",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": null,
          "affected_status": "affected",
          "phenotype_details": "neuropathic amyloidosis",
          "evidence_sentence": "In Sweden, nine homozygous patients from eight families carrying the ATTR mutation Val30Met... have been identified."
        },
        {
          "individual_id": "P7",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": null,
          "affected_status": "affected",
          "phenotype_details": "neuropathic amyloidosis",
          "evidence_sentence": "In Sweden, nine homozygous patients from eight families carrying the ATTR mutation Val30Met... have been identified."
        },
        {
          "individual_id": "P8",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": null,
          "affected_status": "affected",
          "phenotype_details": "neuropathic amyloidosis",
          "evidence_sentence": "In Sweden, nine homozygous patients from eight families carrying the ATTR mutation Val30Met... have been identified."
        },
        {
          "individual_id": "P9",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": null,
          "affected_status": "affected",
          "phenotype_details": "neuropathic amyloidosis",
          "evidence_sentence": "In Sweden, nine homozygous patients from eight families carrying the ATTR mutation Val30Met... have been identified."
        }
      ],
      "functional_data": {
        "summary": "The mutation Val30Met is associated with amyloid formation leading to neuropathic symptoms.",
        "assays": []
      },
      "segregation_data": "Yes, all patients are homozygous for the mutation.",
      "population_frequency": null,
      "evidence_level": "high",
      "source_location": "Main Text, paragraph 1",
      "additional_notes": "All identified patients were homozygous for the Val30Met mutation.",
      "key_quotes": [
        "Homozygosity for the mutation associated with FAP, ATTR Val30Met, does not implicate a more severe phenotype for Swedish patients."
      ]
    }
  ],
  "tables_processed": [],
  "extraction_metadata": {
    "total_variants_found": 1,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All relevant data extracted from the main text."
  }
}